MedPath

CAYSTON

CAYSTON

Approved
DIN Number

02329840

Drug Class

Human

Market Date

Nov 11, 2009

Company
HC

gilead sciences canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02329840
AIG Number0122819004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DF01 AZTREONAM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationInhalation
AHFS Classification08:12.07.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

AZTREONAMActive
Strength: 75 MG / VIAL
Monograph: AZTREONAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.